Click here
Sunday 19 May 2013 Register   Login
Search 
  
You are here:
Home
News
Latest issue
Subscribe
Email bulletin
Suppliers Guide
Advertise
Contact us
New neurology product
Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here
LATEST ISSUE
Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Featured Articles

After TGN1412: the CHMP draft guidelines

Hospital Pharmacy Europe Issue 33 July/August 2007

Issues surrounding application of traditional development strategies to biological products were foregrounded last year when a new antibody caused severe reactions in trial volunteers. Will the incident trigger enhanced guidance on testing humanised medicines?

You must login to continue reading this article


Forgotten your password? Click this button and we will send you a reminder by email.

Password reminder


Not yet registered?
Register now - you will get instant access to this article and many hundreds of others.

Register now


Need advice? Try the help section.
USER TOOLS
About the author
Have your say - comment on this item
Print-friendly version
© Campden Publishing Limited 2013
Site Map | Accessibility | Terms & Conditions | Privacy Policy | Contacts
Campden Publishing Ltd., 140 London Wall London EC2Y 5DN, is a company registered in the United Kingdom with Reg. No. 2147432
www.campden.com

Web design, hosting and programming by ModeZero